Pyogenic granuloma-like acne lesions during isotretinoin therapy.
Three male patients with severe nodulocystic acne were treated with oral isotretinoin in a dosage of 0.5 to 1.0 mg/kg/day. A flare of their disease developed, characterized by an inflammatory, hemorrhagic, pyogenic, granuloma-like response of previously crusted acne lesions. This reaction occurred between the sixth and ninth weeks of treatment and was confined entirely to the chest and back. The severity of the reaction prompted the administration of oral prednisone and, in two cases, the discontinuation of isotretinoin therapy. In one patient, pyoderma gangrenosum developed on the thigh. The exact incidence of this pyogenic, granuloma-like reaction to isotretinoin is unknown, although we have seen it in three of 66 patients with nodulocystic acne treated with this drug. The cause of the reaction is unknown, but it may be due to the increased skin fragility and vascular proliferation known to be induced by isotretinoin.
D000152:Acne Vulgaris / Q000188:drug therapy* / Q000473:pathology; D000284:Administration, Oral; D000328:Adult; D004311:Double-Blind Method; D003875:Drug Eruptions / Q000209:etiology*; D006099:Granuloma / Q000139:chemically induced*; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D015474:Isotretinoin; D008297:Male; D011711:Pyoderma / Q000139:chemically induced*; D012883:Skin Ulcer / Q000139:chemically induced; D014212:Tretinoin / Q000008:administration & dosage / Q000009:adverse effects*
D014212:Tretinoin; D015474:Isotretinoin